The following blog from Mesothelioma.net gives a good summary of CB-839, a glutaminase inhibitor that has been fast tracked by the US Food and Drug Administration (FDA) for the treatment of metastatic renal cell carcinoma (RCC) when used in combination with everolimus.

Read more here